Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Circ Res. 2012 Mar 2;110(5):716-26. doi: 10.1161/CIRCRESAHA.111.256834. Epub 2012 Jan 26.
Vascular endothelial growth factor (VEGF), a major proangiogenic agent, exerts its proangiogenic action by binding to VEGF receptor 2 (VEGFR2), the activity of which is regulated by direct interactions with other cell surface proteins, including integrin α(V)β(3). However, how the interaction between VEGFR2 and integrin α(V)β(3) is regulated is not clear.
To investigate whether Necl-5/poliovirus receptor, an immunoglobulin-like molecule that is known to bind integrin α(V)β(3), regulates the interaction between VEGFR2 and integrin α(V)β(3), and to clarify the role of Necl-5 in the VEGF-induced angiogenesis.
Necl-5-knockout mice displayed no obvious defect in vascular development; however, recovery of blood flow after hindlimb ischemia and the VEGF-induced neovascularization in implanted Matrigel plugs were impaired in Necl-5-knockout mice. To clarify the mechanism of the regulation of angiogenesis by Necl-5, we investigated the roles of Necl-5 in the VEGF-induced angiogenic responses in vitro. Knockdown of Necl-5 by siRNAs in human umbilical vein endothelial cells (HUVECs) inhibited the VEGF-induced capillary-like network formation on Matrigel, migration, and proliferation, and conversely, enhanced apoptosis. Coimmunoprecipitation assays showed the interaction of Necl-5 with VEGFR2, and knockdown of Necl-5 prevented the VEGF-induced interaction of integrin α(V)β(3) with VEGFR2. Knockdown of Necl-5 suppressed the VEGFR2-mediated activation of downstream proangiogenic and survival signals, including Rap1, Akt, and endothelial nitric oxide synthase.
These results demonstrate the critical role of Necl-5 in angiogenesis and suggest that Necl-5 may regulate the VEGF-induced angiogenesis by controlling the interaction of VEGFR2 with integrin α(v)β(3), and the VEGFR2-mediated Rap1-Akt signaling pathway.
血管内皮生长因子 (VEGF) 是一种主要的促血管生成因子,通过与血管内皮生长因子受体 2 (VEGFR2) 结合发挥其促血管生成作用,其活性受与其他细胞表面蛋白(包括整合素 α(V)β(3))的直接相互作用调节。然而,VEGFR2 与整合素 α(V)β(3) 的相互作用如何调节尚不清楚。
研究神经细胞黏附分子 5/脊髓灰质炎病毒受体 (Necl-5/poliovirus receptor) 是否通过与整合素 α(V)β(3) 结合来调节 VEGFR2 与整合素 α(V)β(3) 的相互作用,并阐明 Necl-5 在 VEGF 诱导的血管生成中的作用。
Necl-5 基因敲除小鼠的血管发育没有明显缺陷;然而,敲除 Necl-5 后,后肢缺血后血流恢复和植入 Matrigel 塞中的 VEGF 诱导的新血管形成受损。为了阐明 Necl-5 调节血管生成的机制,我们研究了 Necl-5 在体外 VEGF 诱导的血管生成反应中的作用。人脐静脉内皮细胞 (HUVEC) 中的 Necl-5 通过 siRNAs 敲低抑制了 Matrigel 上 VEGF 诱导的毛细血管样网络形成、迁移和增殖,反之则促进了细胞凋亡。共免疫沉淀实验显示 Necl-5 与 VEGFR2 相互作用,而 Necl-5 的敲低则阻止了 VEGF 诱导的整合素 α(V)β(3) 与 VEGFR2 的相互作用。Necl-5 的敲低抑制了 VEGFR2 介导的下游促血管生成和存活信号的激活,包括 Rap1、Akt 和内皮型一氧化氮合酶。
这些结果表明 Necl-5 在血管生成中起关键作用,并表明 Necl-5 可能通过控制 VEGFR2 与整合素 α(V)β(3) 的相互作用以及 VEGFR2 介导的 Rap1-Akt 信号通路来调节 VEGF 诱导的血管生成。